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Abstract
Background: About 30% of the population worldwide are infected with the protozoan parasite Toxoplasma gondii.
Latent toxoplasmosis has many specific behavioral and physiological effects on the human organism. Modified
reactivity of the immune system has been suggested to play a key role in many of these effects. For example, the
immunosuppression hypothesis explains the higher probability of the birth of male offspring observed in
Toxoplasma-positive humans and mice by the protection of the (more immunogenic) male embryos against
abortion.
Methods: Here we searched for indices of immunosuppression in Toxoplasma-positive subjects by comparing
clinical records of immunology outpatients.
Results: Our cohort study showed that the male patients with latent toxoplasmosis had decreased and the
Toxoplasma-positive women had increased leukocyte, NK-cell and monocyte counts in comparison with controls.
The B-cell counts were reduced in both Toxoplasma-positive men and women. The difference between
Toxoplasma-positive and Toxoplasma-negative subjects diminished with the decline of the specific Toxoplasma
antibody titre (a proxy for the length of infection), which is consistent with the observed decreasing strength of
the effect of latent toxoplasmosis on human reproduction. The prevalence of toxoplasmosis in 128 male patients
was unusually low (10.9%) which contrasted with normal prevalence in 312 female patients (23.7%) and in general
population Prague (20-30%).
Conclusions: Latent toxoplasmosis has immunomodulatory effects in human and probably protects men against
some classes of immunopathological diseases. The main limitation of the present study was the absence of the
data on the immunoreactivity of immune cells subpopulations. Therefore further studies are needed to search for
indices of immunosuppression in human using more specific markers.
Background
Toxoplasma gondii, a parasitic protozoan related to
Plasmodium, infects about 30% of the human popula-
tion worldwide. Latent toxoplasmosis, characterized by
the life-long presence of cysts of the parasite in different
host tissues, including the nervous system, and by the
presence of anamnestic Toxoplasma IgG antibodies in
the serum, was long considered asymptomatic. In the
past 20 years, several effects of this form of parasitosis
on the human organism were described in the literature.
For example, latent toxoplasmosis increases the risk of
schizophrenia [1] and Parkinson’s disease [2] influences
human personality and behavior [3,4], impairs psycho-
motor performance, enhances the risk of suicide [5], of
traffic accident [6-9] and increases probability of the
birth of male offspring [10,11]. Reportedly, the activity
of the immune system is likely to play an important role
in many of the observed effects of Toxoplasma infection.
For example, the impairment of the immune system has
been suggested to be at least partly responsible for the
observed association between toxoplasmosis and schizo-
phrenia [3]. Also, many of the observed behavioural
effects of toxoplasmosis might be a result of the
increased level of dopamine in the brain tissue in
response to IL-2 produced by immune cells in the sites
of local inflammation in the infected brain [12-14].
Similarly, the effect of latent toxoplasmosis on human
reproduction, not only on the probability of the birth of
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a child with Down syndrome [15] and on the length of
pregnancy [16], has been assumed to be a consequence
of toxoplasmosis-associated immunosuppression. It is
well known that most of the embryos, especially the
more immunogenic male embryos and those with var-
ious chromosomal aberrations and physical malforma-
tions, are aborted in early phases of pregnancy[17,18].
The immunosuppression hypothesis suggests that Toxo-
plasma relaxes the stringency of some mechanisms of
quality control of early embryos to increase the prob-
ability of its transmission to the next generation through
the congenitally infected offspring [10,11].
Many reports are available concerning the effect of
acute toxoplasmosis on the immunity of humans or
mice [19-21]. However, the data showing similar effects
in congenital toxoplasmosis are absent. The results
obtained in infected laboratory female mice showed that
mice in the early phase of latent infection exhibited
temporarily increased production of IL-12 and decreased
production of IL-10. In accordance with the immuno-
suppression hypothesis, the mice showed decreased pro-
duction of IL-2 and nitric oxide and decreased synthesis
of DNA in the mixed lymphocyte assay in the early and
also in the late phases of latent toxoplasmosis [22]. It is
difficult to study such effects in mouse models, as the
duration of acute and post-acute stages of infection
approaches the normal length of life in this species. On
the other hand, there is a striking difference between
the about one-month acute infection and life-long latent
infection in humans. In the present cohort study, we
searched for indices of immunomodulation in humans
with latent toxoplasmosis by comparing the available
clinical records, namely the flow cytometry and haema-
tological data, in Toxoplasma-positive (infected) and
Toxoplasma-negative (noninfected) outpatients under-
going routine immunological tests at the Institute of
Clinical and Experimental Medicine in Prague.
Methods
Subjects
The experimental design of present study was a pro-
spective cohort study. Clinical data of all immunology
outpatients of the Institute of Clinical and Experimental
Medicine in Prague from 2008-2009 were anonymized
and analyzed for possible association between latent tox-
oplasmosis (anamnestic titres of Toxoplasma antibodies
in frozen samples of sera collected for clinical analysis)
and immune cell counts. Diagnosis (ICD-10) of most
subjects (250 ×) was D89.9 (disorder involving the
immune mechanism, unspecified) and J30.1-3 seasonal
allergic rhinitis (117 ×). Other diagnoses observed in
our analysed population were A69.2 (2 ×), B009 (3 ×),
B007 (2 ×), D80.0 (1 ×), D80.2 (1 ×), D80.6 (1 ×), D81.9
(10 ×), D83.9 (2 ×), D89.8, E06.3 (2 ×), F48.0 (3 ×),
H 1 0 . 1( 1× ) ,H 1 0 . 9( 1× ) ,J 0 1 . 0( 1× ) ,J 0 6 . 8( 1× ) ,J 0 6 . 9
(1 ×), J30.0 (1 ×), J30.3 (12 ×), J45.0 (11 ×), J45.9 (10 ×),
K30 (1 ×), K50.9 (6 ×), M05.9 (1 ×), M35.0 (1 ×), N76.1
(2 ×), O26.9 (1 ×), T63.4 (1 ×), T78.4 (1 ×). We analysed
the whole population of patients and also two subpopu-
lations separately: patients with immunodeficiencies
D89.9 and patients with allergies, J30.0-4, J45.0, J45.9.
The subjects with D89.1 diagnosis were mostly
untreated, while the standard medication with second
generation antihistamines and topical corticosteroids
was used in allergic patients. This treatment can influ-
ence (decrease) the cell counts but does not affect pro-
portion of particular cell types in the peripheral blood.
There were no patients under systemic corticotherapy in
any of the groups. The study was approved by the Insti-
tutional Review Board of the Faculty of Science, Charles
University (Apr. No. 2008/3).
Serological tests for toxoplasmosis
All serological tests were carried out in the National
Reference Laboratory for Toxoplasmosis, National Insti-
tute of Public Health, Prague. All study subjects were
screened for specific Toxoplasma IgG antibodies and
those with high IgG levels were tested for IgM antibo-
dies by ELISA (IgG: SEVAC, Prague, IgM: TestLine,
Brno; optimized for early detection of acute toxoplasmo-
sis) and the complement fixation test (CFT) (SEVAC,
Prague) [23], at dilutions between 1:4 and 1:1024. The
subjects IgM negative (positivity index < 0.9) and IgG
positive by ELISA (positivity index > 1.0) were consid-
ered latent toxoplasmosis positive. None of the study
subjects had a CFT titre higher than 1:128 or an index
for IgM higher than 0.9.
Statistics
The effects of sex and age on the risk of latent toxoplas-
mosis were tested with logistic regression. Effects of tox-
oplasmosis, sex and age on the immune cells counts
were quantified with GLM and correlation between CFT
titres and immune cells counts in subjects with latent
toxoplasmosis was analyzed with a non-parametric test,
namely partial Kendall regression analysis with age as a
covariate. All variables except the fraction of lympho-
cytes and erythrocytes were log transformed to achieve
an approximately normal distribution.
Results
The studied population consisted of 440 patients, 312
women and 128 men. The mean age of 238 Toxo-
plasma-negative women (40.22, SD = 17.21) was signifi-
cantly lower than that of 74 (23.7%) Toxoplasma-
positive women (49.11, SD = 13.72), P < 0.0001. Simi-
larly, 114 Toxoplasma-negative men (36.04, SD = 18.28)
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positive men (50.14, SD = 19.32), P < 0.008. The logistic
regression with the dependent variable toxoplasmosis
and independent variables sex and age showed that men
had a significantly lower probability of Toxoplasma
infection than women (P = 0.009, OR = 0.43, CI95 =
0.23-0.81) and the probability of being Toxoplasma posi-
tive increased with each year of age (P < 0.0001, OR =
1.035, CI95 = 1.02-1.05). No effect of the diagnosis on
probability of the Toxoplasma infection was observed
when the binary variable diagnosis (immunodeficiency
yes/no) was included into the model (P =0 . 7 7 9 ,O R=
0.920, CI95 = 0.51-1.65).
General linear model analyses with particular haema-
tological or flow-cytometry parameters as dependent
factors, toxoplasmosis (binary) and sex (binary) as inde-
pendent factors and age (continuous) as a confounding
variable showed that toxoplasmosis correlates with sev-
eral haematological and cytometric parameters, namely
the leukocyte, CD19, CD16 + 56 and monocyte counts,
mostly shifting the size of immune cell subpopulations
in opposite directions in men and women (Tables 1 and
2). The separate GLM analyses performed for patients
with immunodeficiencies and patients with allergies and
asthma showed that that the former subpopulation was
probably responsible for the observed effects.
Although the length of infection in particular Toxo-
plasma-positive patients is unknown, it can be estimated
from the level of Toxoplasma antibodies measured by
CFT. Unlike the irregularly fluctuating concentrations of
antibodies measured by ELISA, the CFT titres have been
reported to decrease slowly and relatively regularly in
years after the infection [23]. Results of the partial Ken-
dall regression analysis with age as a covariate showed
that leukocytes, CD19, CD16 + 56 and monocytes had a
non-significant tendency to return to normal with
decreasing CFT titres of Toxoplasma antibodies, for
monocytes in women this tendency was significant (par-
tial Kendall Tau = 0.170, P = 0.028), see Figure 1.
Discussion
The prevalence of latent toxoplasmosis was significantly
higher in female (23.7%) than in male (10.9%) patients.
Patients with or without anamnestic titres of Toxo-
plasma antibodies, i.e. with or without latent toxoplas-
mosis, differed from each others in several important
parameters, namely in the counts of leukocytes, CD19
cells (B-cells), CD16 + 36 cells (natural killers) and
Table 1 Comparison of the haematological data from Toxoplasma-negative and Toxoplasma-positive men and women
Age
P
Sex
P
Toxo
P
sex-toxo
P
women-neg
mean
women-pos
mean
men-neg
mean
men-pos
mean
all immunology outpatients N = 440
leukocytes (× 10
6/L) 0.412 0.002* 0.502 0.054 6913.136 7229.730 6572.973 5750.000
neutrophils (× 10
9/L) 0.011* 0.009* 0.811 0.184 4.059 4.471 3.729 3.396
lymphocytes (× 10
9/L) 0.000* 0.047* 0.719 0.152 2.015 1.985 1.997 1.644
monocytes (× 10
9/L) 0.751 0.506 0.107 0.024* 0.508 0.518 0.548 0.451
eosinophils (× 10
9/L) 0.423 0.227 0.793 0.699 0.185 0.201 0.223 0.216
basophils (× 10
9/L) 0.581 0.016* 0.185 0.250 0.047 0.046 0.042 0.032
patients with allergies, seasonal allergic rhinitis J.30.1-4, N = 117
leukocytes (× 10
6/L) 0.600 0.191 0.268 0.351 689.059 774.375 667.500 668.000
neutrophils (× 10
9/L) 0.511 0.111 0.326 0.339 4.058 4.924 3.733 3.892
lymphocytes (× 10
9/L) 0.006* 0.961 0.666 0.991 2.020 1.953 2.128 1.990
monocytes (× 10
9/L) 0.701 0.329 0.502 0.421 0.475 0.534 0.555 0.544
eosinophils (× 10
9/L) 0.278 0.641 0.320 0.496 0.200 0.269 0.224 0.218
basophils (× 10
9/L) 0.858 0.120 0.483 0.630 0.050 0.049 0.041 0.032
patients with immunodeficiencies, D89.9, N = 250
leukocytes (× 10
6/L) 0.958 0.049* 0.152 0.053 670.876 690.000 669.677 535.714
neutrophils (× 10
9/L) 0.078 0.067 0.282 0.184 4.026 4.176 3.832 3.207
lymphocytes (× 10
9/L) 0.000* 0.129 0.256 0.051 1.937 1.977 2.022 1.440
monocytes (× 10
9/L) 0.800 0.329 0.039* 0.018* 0.505 0.512 0.549 0.406
eosinophils (× 10
9/L) 0.919 0.065 0.806 0.937 0.180 0.190 0.241 0.246
basophils (× 10
9/L) 0.121 0.175 0.172 0.201 0.045 0.045 0.044 0.031
Columns 3-6 show the significance (P ) of effects of age, sex, latent toxoplasmosis and toxoplasmosis-sex interaction for the whole population, patients with
seasonal allergic rhinitis and patients with immunodeficiencies.Columns 7-10 show the arithmetic means of various variables in particular subpopulations. The P
value = 0.000 means P < 0.0005, the significant P -values (P < 0.05) are denoted with asterisks, the trends P < 0.10 are, printed in bold.
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infected men and women; however, all the other
immune cell counts were higher in infected women and
lower in infected men. Such shifts in the counts of parti-
cular immune cells to the opposite directions are likely
to be side effects of the infection rather than a result of
the biological adaptation of the parasite aimed to
increase the probability of survival in the host organism
by modulating its immunoreactivity.
The opposite effects of toxoplasmosis in men and
women were also observed in the personality profile
[3,24] and behaviour [25,26]. The key to such opposite
behavioral and immunological effects in infected men
and women might be the variation in the effects of Tox-
oplasma infection on the concentration of free testoster-
one. Reportedly, infected men had increased while
infected women decreased testosterone levels in com-
parison with controls [27,28]. Testosterone is known to
have specific effects on the behaviour as well as the
immunity of animals, including humans. The increased
level of testosterone is generally associated with the
immunosuppression [29,30] which could explain both
the decreased number of leukocytes, B-cells, NK-cells
and monocytes in men and the increased size of
leukocyte, NK-cell and monocyte populations in women.
It must be remind, however, that experiments per-
formed with artificially infected laboratory mice demon-
strated decreased level of testosterone in both males and
females. Moreover, we did not found any significant dif-
ferences in the concentration of testosterone between
Toxoplasma-positive and Toxoplasma-negative solders
(nonpublished results). It is critically needed to search
for changes of cell counts in the Toxoplasma-infected
mice and also to search for possible correlation between
concentration of testosterone and blood cell count in
our patients.
The trend towards a slow return of the immune cell
counts to normal suggests that the observed differences
are a carry-out effect of acute infection rather than a
consequence of latent toxoplasmosis. It must be remind
that this trend was significant only for monocytes in
women. For leukocytes, CD19 and CD16 + 56 cells, and
monocytes in men the cell counts returned to normal
value in subjects with oldest infection, however, the
trend was nonsignificant due to large variance in cell
counts and low number of infected subjects. The corre-
lation between cell counts and duration of the infection
also indicates that toxoplasmosis induces changes in the
Table 2 Comparison of the flow cytometry data from Toxoplasma-negative and Toxoplasma-positive men and women
Age
P
Sex
P
Toxo
P
sex-toxo
P
women-neg
mean
women-pos
mean
men-neg
mean
men-pos
mean
all immunology outpatients N = 440
CD3 (× 10
6/L) 0.000* 0.009* 0.599 0.164 1549.190 1507.236 1481.540 1190.571
CD19 (× 10
6/L) 0.000* 0.002* 0.045* 0.012* 254.091 224.514 262.205 155.143
CD4 (× 10
6/L) 0.000* 0.000* 0.474 0.149 989.026 977.625 878.469 722.786
CD8 (× 10
6/L) 0.000* 0.395 0.974 0.439 512.725 490.028 527.973 431.429
CD16 + 56 (× 10
6/L) 0.709 0.861 0.508 0.016* 215.268 243.722 257.795 208.857
CD4/CD8 0.001* 0.021* 0.835 0.875 2.162 2.211 1.809 2.020
patients with allergies, seasonal allergic rhinitis and asthma J.30.1-4, N = 117
CD3 (× 10
6/L) 0.002* 0.291 0.990 0.920 1566.797 1444.375 1544.031 1331.600
CD19 (× 10
6/L) 0.000* 0.852 0.723 0.208 223.625 232.063 279.469 205.200
CD4 (× 10
6/L) 0.026* 0.121 0.621 0.731 979.719 930.875 855.938 839.000
CD8 (× 10
6/L) 0.074 0.704 0.549 0.856 532.062 443.125 574.125 491.000
CD16 + 56 (× 10
6/L) 0.180 0.913 0.866 0.032* 223.652 319.500 283.788 236.000
CD4/CD8 0.011* 0.727 0.648 0.400 2.069 2.174 1.661 2.222
patients with immunodeficiencies, D89.9, N = 250
CD3 (× 10
6/L) 0.000* 0.077 0.423 0.112 1479.986 1509.234 1481.694 1105.000
CD19 (× 10
6/L) 0.000* 0.141 0.116 0.210 249.216 220.213 251.613 128.143
CD4 (× 10
6/L) 0.065 0.007* 0.251 0.089 950.075 972.426 884.903 635.000
CD8 (× 10
6/L) 0.000* 0.829 0.877 0.299 486.552 505.149 534.807 419.429
CD16 + 56 (× 10
6/L) 0.992 0.875 0.271 0.161 211.745 218.851 250.985 187.571
CD4/CD8 0.000* 0.023 0.463 0.570 2.176 2.232 1.816 1.792
Columns 3-6 show the significance (P ) of effects of age, sex, latent toxoplasmosis and toxoplasmosis-sex interaction for the whole population, patients with
seasonal allergic rhinitis and patients with immunodeficiencies. Columns 7-10 show the arithmetic means of various variables in particular subpopulations. The P
value = 0.000 means P < 0.0005, the significant P -values (P < 0.05) are denoted with asterisks, the trends P < 0.10 are, printed in bold..
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immune system increases the risk of Toxoplasma infec-
tion. The return of the immune cell counts to normal is
in accordance with the diminishing effect of latent toxo-
plasmosis on the sex ratio in women and female mice.
The increased probability of the birth of male offspring
was only observed in women with high or moderate
levels of Toxoplasma antibodies and in female mice 2-4
months after the infection. In women with low or mod-
erate levels of Toxoplasma antibodies and in female
mice more than 4 months after the infection, the prob-
ability of the birth of male offspring was even lower
than in uninfected controls. It was suggested that the
increased sex ratio in women and mice in early phases
of latent toxoplasmosis was caused by immunosuppres-
sion that protects the more immunogenic males
embryos against abortion. For example, in humans, the
sex ratio decreases from about 2.6 in the first weeks of
pregnancy to about 1.06 at the time of delivery [17,18].
The diminishing effect of toxoplasmosis on immune cell
counts is in accordance with the expected decrease of
immunosuppression.
The most obvious problem of our study was related to
low number of Toxoplasma-positive men in our popula-
tion. The unbalanced design can result in false negative
result - i.e. in missing some effects of toxoplasmosis. It
must be stressed, however, that it cannot lead in false
positive results, i.e. in detection of non-existent effects
of toxoplasmosis.
The main limitation of the present study was the
absence of the data on the immunoreactivity of immune
cells subpopulations. We searched for indices of immu-
nosuppression using only the clinical data that are routi-
nely collected from patients with allergic diseases.
Recent results obtained in infected laboratory female
mice suggest that the concentrations of important inter-
leukins are increased; however, the reactivity of immune
cells measured by nitric oxide production and prolifera-
tion of stimulated spleen cells in the MLC assay are
considerably decreased in comparison with uninfected
controls [22]. Further studies are needed to search for
indices of immunosuppression using more specific mar-
kers. The second potential limitation of the present
study is the selected population group. The patients
Figure 1 Correlation between the CFT titres of Toxoplasma antibodies and monocyte counts. The CFT titres decrease with the length of
Toxoplasma infection. The monocyte count (y-axis) is shown in 10
9 per liter. a) women, b) men. Number of patients with titres 64, 32, 16, 8, 4
and <4 was 4, 14, 37, 45, 45 and 295, respectively.
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specific cohort and their immunological data can hardly
be generalized to the normal healthy population. Theo-
retically, subjects with toxoplasmosis-associated immu-
nosuppression might be protected against severe
allergies, thus escaping inclusion in our study. The pre-
valence of latent toxoplasmosis is significantly lower
among our male than female patients, although in the
Czech general population, the prevalence rates of toxo-
plasmosis are approximately the same in men and
women [31]. Possibly, the Toxoplasma-positive men
(with decreased counts of leukocytes, B-cells, NK cells
and monocytes) are protected against allergies and
therefore were not enrolled in our study, while the
women (with increased counts of total leukocytes, NK-
cells and monocytes) have higher probability of allergies
and immunopathological diseases. Decreased frequency
of Toxoplasma-positive subjects in patients with atopic
disease has already reported in several studies [32-34]. It
must be remind, however, the low frequency of Toxo-
plasma infected men as well as the statistically signifi-
cant associations between the Toxoplasma infection and
t h ec e l lc o u n t sw e r eo b s e r v e dm o s t l yi ns u b j e c t sw i t h
immunodeficiencies (D.89.9) not in patients with aller-
gies (J.30.1-4) in our study.
Conclusions
We can conclude that the data from the outpatient
immunology clinic suggest specific effects of latent toxo-
plasmosis on humans. The effects decreased with the
length of infection and were opposite in direction in
men and women, possibly as a result of the reported
opposite effects of the infection on the level of testoster-
one in men and women. Given the high prevalence of
latent toxoplasmosis, its possible immunosuppressive
effects, although relatively weak in individual patients,
might have a considerable impact on the health of the
world population.
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